Search Results

The Leukemia & Lymphoma Society, now Blood Cancer United, Kicks off Light The Night  Season During Blood Cancer Awareness Month

New Brand Identity Introduced at Iconic Philanthropic Events Bringing Communities Together Across the Country …

Solo para adolescentes

Como adolescente con cáncer de la sangre, te enfrentas a orientarte en la escuela, las amistades y ante una enfermedad que no esperaste. Te entendemos…

Guías de preguntas imprimibles

Holly

In , I joined The Leukemia & Lymphoma Society (LLS) Tennessee Chapter as a supportive member of Team Addie. I had friends who became team members the …

Alimentos y nutrición

Russ

Shockingly I was diagnosed with acute myeloid leukemia (AML) on February , ! My wife Nancy and I were devastated and had zero background or experience…

Blood Cancer United’s Shred For Red Hits the Slopes This Spring at Deer Valley

The largest global nonprofit focused on serving blood cancer patients, The Leukemia & Lymphoma Society, which is now Blood Cancer United®, is proud to…

New Report: Blood Cancer United Proposes Industry Reforms to Lower Healthcare Costs

Soaring healthcare costs and industry practices contributing to them are increasingly making cancer treatment out of reach for many U.S. patients, cau…

Survivorship workbooks

Use the Survivorship Workbook to collect all the important information you need throughout diagnosis, treatment, care and management of a blood canc…

Continued Collaboration Fuels Hope for Rare Blood Cancer Treatments

The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society, now Blood Cancer United, have renewed their partnership to support the …

Blood Cancer United Responds to Federal Funding Crisis with $8 Million Gift from Big Nova Foundation

Blood Cancer United, formerly The Leukemia & Lymphoma Society, today announced a transformative $ million gift from the Big Nova Foundation. This com…

DNA damage, immune response, aging and leukemia

Hematopoiesis is tightly regulated by intrinsic and extrinsic signals, alterations of which can affect hematopoietic stem cell (HSC) function and lead…

Wei Du

My research is centered on pathophysiology of hematologic diseases such as bone marrow failure and leukemia, with specific focus on hematopoietic stem…

Biology and therapeutic targeting of cohesin mutations during myeloid malignancy development

We investigate the biology, genetics and treatment of myeloid malignancies, including CHIP, MDS and AML. Our goal is to improve our understanding of t…

Building Upon The Success Of CART19: Safe and Effective Next-Generation CART For Relapsed And Refractory Lymphomas

My group studies the mechanisms of relapse and toxicity after chimeric antigen receptor T cell (CART) immunotherapy to rationally design innovative i…

Improving Immunotherapy in Multiple Myeloma Through Innovative Clinical Trials, Real-World Evidence and Correlative Research

The overall focus of my research is improving outcomes with immunotherapy in multiple myeloma. I will accomplish this through ) novel clinical trials…

Surbhi Sidana

I am a hematologist/oncologist specializing in the treatment of multiple myeloma and related disorders. I am an Associate Professor in the Division of…

Leveraging multispecific antibodies to reshape the treatment landscape of B-cell non-Hodgkin lymphoma

I focus on developing bispecific antibodies (BsAb) for the treatment of lymphoma (). We are testing epcoritamab or mosunetuzumab combinations in fo…

Lorenzo Falchi

Dr. Falchi graduated Cum Laude from the University of Perugia, Italy. He completed a postdoctoral fellowship at MD Anderson Cancer Center, residency a…

Biomarker and Risk Tailored Treatment to Improve Outcomes in Diffuse Large B-cell Lymphoma

Improving survival for patients with diffuse large lymphoma requires tailoring treatment to lymphoma genetic heterogeneity, addressing minimal residu…

Dai Chihara

Dai Chihara, MD, PhD is an Associate Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center in Houston, TX. Dr. Chihara rece…

Welcome to Blood Cancer United

Things look a little different around here. The Leukemia & Lymphoma Society (LLS) has a new name: Blood Cancer United. You may be asking a question we…

More than a campaign: centering people with blood cancer

This fall, for the first time in more than a decade, we launched a national advertising campaign not just to share our new name—Blood Cancer United—bu…

Uncovering immune evasion mechanisms and therapeutic targets in B-cell lymphomas via macrophage reprogramming

EZB lymphomas, driven by BCL2 translocations and EZH2 mutations, induce macrophages to adopt a supportive role, essential for maintaining the malignan…

Xi Chen

I completed my Ph.D. in pharmacology at Zhejiang University, China, in June , specializing in cancer immunology. My doctoral research provided traini…